Lucid Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.About LUCD
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
CEOLishan Aklog
CEOLishan Aklog
Employees72
Employees72
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees72
Employees72
LUCD Key Statistics
Market cap146.18M
Market cap146.18M
Price-Earnings ratio-1.24
Price-Earnings ratio-1.24
Dividend yield—
Dividend yield—
Average volume717.27K
Average volume717.27K
High today$1.15
High today$1.15
Low today$1.08
Low today$1.08
Open price$1.14
Open price$1.14
Volume648.14K
Volume648.14K
52 Week high$1.80
52 Week high$1.80
52 Week low$0.7501
52 Week low$0.7501
Stock Snapshot
With a market cap of 146.18M, Lucid Diagnostics(LUCD) trades at $1.09. The stock has a price-to-earnings ratio of -1.24.
On 2025-12-18, Lucid Diagnostics(LUCD) stock traded between a low of $1.08 and a high of $1.15. Shares are currently priced at $1.09, which is +0.9% above the low and -5.2% below the high.
The Lucid Diagnostics(LUCD)'s current trading volume is 648.14K, compared to an average daily volume of 717.27K.
During the past year, Lucid Diagnostics(LUCD) stock moved between $0.75 at its lowest and $1.80 at its peak.
During the past year, Lucid Diagnostics(LUCD) stock moved between $0.75 at its lowest and $1.80 at its peak.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LUCD. This list is generated using Robinhood data, and it’s not a recommendation.